Pittsburgh's UPMC has signed up three big partners--Merck, Battelle, and IBM--in its $900 million plan to develop a its first-of-its-kind vaccine factory, reports the Pittsburgh Business Times.
The new partners join GE Healthcare in pursuing construction of the facility. The plant would be funded by the federal government and operate as a nonprofit UPMC subsidiary. Last year, UPMC President and CEO Jeffrey Romoff said he favored a site near the old Pittsburgh International Airport for the factory.
21CB is the nonprofit corporation created by UPMC last year to own and operate the facility, which will create 1,000 jobs directly and up to 6,000 jobs indirectly, according to UPMC.
Original source: Pittsburgh Business TimesRead the full story here.